Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance

N Ebrahimi, M Afshinpour, SS Fakhr… - Critical Reviews in …, 2023 - Elsevier
Colorectal cancer (CRC) is the third cause of cancer death worldwide. Although, in some
cases, treatment can increase patient survival and reduce cancer recurrence, in many …

Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives

G Moore, S Annett, L McClements, T Robson - Cells, 2020 - mdpi.com
Evolutionarily conserved Notch plays a critical role in embryonic development and cellular
self-renewal. It has both tumour suppressor and oncogenic activity, the latter of which is …

Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: current status and future perspectives

MA Ansari, M Thiruvengadam, B Venkidasamy… - Seminars in cancer …, 2022 - Elsevier
Cancer is one of the dreadful diseases worldwide. Surgery, radiation and chemotherapy, are
the three basic standard modes of cancer treatment. However, difficulties in cancer treatment …

Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies

J He, Z Qiu, J Fan, X Xie, Q Sheng, X Sui - Signal transduction and …, 2024 - nature.com
Non-genetic mechanisms have recently emerged as important drivers of anticancer drug
resistance. Among these, the drug tolerant persister (DTP) cell phenotype is attracting more …

Novel strategies to reverse chemoresistance in colorectal cancer

SC Ma, JQ Zhang, TH Yan, MX Miao, YM Cao… - Cancer …, 2023 - Wiley Online Library
Colorectal cancer (CRC) is a common gastrointestinal malignancy with high morbidity and
fatality. Chemotherapy, as traditional therapy for CRC, has exerted well antitumor effect and …

Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo

MA Younis, IA Khalil, YHA Elewa, Y Kon… - Journal of Controlled …, 2021 - Elsevier
Hepatocellular carcinoma (HCC) is a fatal disease with limited therapeutic choices. The
stroma-rich tumor microenvironment hinders the in vivo delivery of most nanomedicines …

Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials

M Housini, B Dariya, N Ahmed, A Stevens, H Fiadjoe… - Gene, 2024 - Elsevier
Colorectal cancer (CRC) is the third most commonly detected cancer with a serious global
health issue. The rates for incidence and mortality for CRC are alarming, especially since …

Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers

V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - mdpi.com
Simple Summary A subset of colorectal cancers (CRCs) is characterized by a mismatch
repair deficiency that is frequently associated with microsatellite instability (MSI). The …

MicroRNAs and colorectal cancer chemoresistance: New solution for old problem

M Vaghari-Tabari, M Majidinia, S Moein, D Qujeq… - Life Sciences, 2020 - Elsevier
Background Colorectal cancer (CRC) is one of the most common gastrointestinal
malignancies with a significant mortality rate. Despite the great advances in cancer …

[HTML][HTML] HIPK2 in cancer biology and therapy: Recent findings and future perspectives

A Conte, V Valente, S Paladino, GM Pierantoni - Cellular Signalling, 2023 - Elsevier
Homeodomain-interacting protein kinase 2 (HIPK2) is a serine-threonine kinase that
phosphorylates and regulates a plethora of transcriptional regulators and chromatin …